SD Biotechnologies delays shareholder vote, shifts reverse stock split timeline to Dec. 3 listing
Bitget2026/09/23 04:49- SD Biotechnologies revised its reverse stock split timetable due to a delay in holding an extraordinary shareholders’ meeting.
- The meeting date was moved to Oct. 15, 2026 from Oct. 8, 2026.
- New shares will take effect Nov. 17, 2026; trading will be halted Nov. 13–Dec. 2, 2026; relisting is set for Dec. 3, 2026.
- The reverse split keeps par value at KRW 1,000 from KRW 200; common shares outstanding will drop to 21,946,628 from 109,733,141.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pre-orders for GTA 6 are booming and may reverse the downward trend! Citigroup raises Take-Two Interactive Software (TTWO.US) target to $270
Citigroup maintains a "Buy" rating on Take-Two Interactive Software, with a target price of $270.
Silver Price Forecast: XAG/USD trades flat around $53 ahead of US inflation data
Swiss Franc holds ground as US Dollar consolidates ahead of CPI inflation data

Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.